earn balanc on-going rx
pressur potenti new teammat
near-term focu pace same-stor script growth
ahead walgreen earn highlight view import factor
quarter walgreen see level benefit recent file buy
fred given purchas pharmaci file fred septemb
transfer expect complet pharmaci would repres
wba total store count estim uplift comp
deal obvious depend script start transfer sinc
full transfer still complet walgreen also see continu pressur
quarter partnership chang silverscript /aetna relationship
look see much modest prescript loss walgreen relat
prefer network chang prescript vs last year walgreen
somewhat off-set sg leverag someth compani continu
leverag first quarter final think pace gross margin
core gross profit growth wide follow recent sg manag
off-set continu pressur margin rate well sustain gross profit
slightli increas ep estim ahead earn primarili increment
cost cut well larger contribut capit deploy increas
ep ep also
increas price object po still repres roughli
ep despit modestli higher estim po remain concern
pace core gross profit growth thu reiter under-perform rate
bodi report detail
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
walgreen follow complet rite
aid store acquisit largest global
pharmaci nearli store us
alon compani also oper intern
pharmaci busi primarili compos
boot pharmaci unit kingdom
allianc healthcar intern wholesal
distributor pharmaceut medic
product europ walgreen headquart
under-perform rate predic
market headwind competit dynam
exacerb concern around pend
amazon entri market core profit
dollar growth slow think limit visibl
creat challeng near-term stock
perform view range-bound
long-term focu expans partnership model
walgreen made stride partnership push across healthcar
servic front store strike deal link labcorp link
link birchbox link link typic walgreen partnership begin
small expand time compani recent expand labcorp partnership
includ lab open walgreen locat next four year
partnership much less matur compani pursu small pilot senior
care kansa citi addit pursu new store format gainesvil
florida locat focus lab servic acut care provid partnership
view biggest question walgreen share econom
variou channel partner whether partnership model success recreat
compani like cvs/aetna cigna/express script tri also
import see walgreen look brand retail partnership
kroger/birchbox whether consum feel comfort pick groceri
place could draw blood
walgreen appear trade much market share
walgreen trade signific part market share
compani appear relax approach estim market share
walgreen chang prescript compar
prescript recal gain signific prescript
partner aetna becom prefer pharmaci shift
silverscript open network prefer network importantli
suggest race bottom medicar part prescript least paus
year could signal ration price time
may hurt wba/wmt shift prefer open network
humana enhanc rx prefer rx plan switch prefer
network provid discount walgreen open network
offer similar price across pharmaci plan combin live
novemb estim walgreen could lose percentag point
market share relat chang estim everi share loss walgreen
past year pbm aggress shift contract employ away
rebat includ express script announc nation drug
purchas coalit net price model announc week ago
believ put pressur pbm margin els equal histor
pbm see margin pressur compani done good job pass margin
pressur chain pharmaci ex dir fee gener reimburs etc
see theme play act pressur margin walgreen
current trade premium recent averag
share current trade next twelv month ebitda premium
averag premium averag
past year trade high ebitda low ebitda today
trade premium trade ebitda expect
premium multipl declin next year wba path consist ebit growth
becom difficult
exhibit part network chang modest impact estim gain prescript lose
new
number
compani name
unitedhealthcar medicarerx group pdp
silverscript group state ny pdp
chang network live
chang rx
prefer network
exist
new prefer network
exist
switch prefer open
switch prefer open
new point sale rebat plan prefer
new plan albertson prefer
total medicar part rx
market share gain allur assum enrol
exhibit despit beat estim last year stock half time earn
exhibit current trade signific premium ev-to-ebitda basi
price object base ep multipl
five-year averag absolut basi around discount five-year
averag reflect view walgreen core retail pharmaci busi long-
term structur pressur must diversifi stabl busi line improv
upsid risk better expect gener save addit volum
econdisc/rit aid new partnership healthcar support long-term growth
contribut addit new partnership faster expect growth
prime relationship downsid risk po greater expect
prescript attrit part relationship integr risk
risk amazon anoth disrupt forc enter suppli chain market
lack avail attract capit deploy opportun
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
